Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19
- DOI
- 10.1186/s12934-024-02320-5
- Published
- 2024-02-06
- Container
- Microbial Cell Factories
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12934-024-02320-5,
title = {Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19},
author = {Norma A. Valdez‑Cruz and Diego Rosiles-Becerril and Constanza E. Martínez-Olivares and Enrique García‑Hernández and Laura Cobos-Marín and Daniel Garzón and Francisco E. López-Salas and Guadalupe Zavala and Axel Luviano and Alejandro Olvera and Alejandro Alagón and Octavio T. Ramírez and Mauricio A. Trujillo‑Roldán},
year = {2024},
journal = {Microbial Cell Factories},
doi = {10.1186/s12934-024-02320-5},
url = {https://doi.org/10.1186/s12934-024-02320-5}
}RIS
TY - JOUR TI - Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19 AU - Norma A. Valdez‑Cruz AU - Diego Rosiles-Becerril AU - Constanza E. Martínez-Olivares AU - Enrique García‑Hernández AU - Laura Cobos-Marín AU - Daniel Garzón AU - Francisco E. López-Salas AU - Guadalupe Zavala AU - Axel Luviano AU - Alejandro Olvera AU - Alejandro Alagón AU - Octavio T. Ramírez AU - Mauricio A. Trujillo‑Roldán PY - 2024 JO - Microbial Cell Factories DO - 10.1186/s12934-024-02320-5 UR - https://doi.org/10.1186/s12934-024-02320-5 ER -
APA
Valdez‑Cruz, N. A., Rosiles-Becerril, D., Martínez-Olivares, C. E., García‑Hernández, E., Cobos-Marín, L., Garzón, D., López-Salas, F. E., Zavala, G., Luviano, A., Olvera, A., Alagón, A., Ramírez, O. T., & Trujillo‑Roldán, M. A. (2024). Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19. Microbial Cell Factories. https://doi.org/10.1186/s12934-024-02320-5
Source records
- crossref · retrieved 2026-09-27T02:30:57.082Z